Literature DB >> 1530812

Lipocortin I production by human alveolar macrophages.

M P Ambrose1, C L Bahns, G W Hunninghake.   

Abstract

Lipocortin I, in some cells, may be a potent inhibitor of phospholipase A2 activity. These studies evaluated the relative amounts of lipocortin I in human alveolar macrophages compared with blood monocytes, using a specific polyclonal antibody and the technique of Western analysis. Lipocortin I was detected in all isolates of human alveolar macrophages and had molecular masses of 37,000 and 33,000 D. Corticosteroids increased amounts of lipocortin I in these cells in a dose-dependent manner. This effect was specific for corticosteroids as related steroids had no effect. Blood monocytes, when compared with alveolar macrophages, contained relatively small amounts of lipocortin I. We conclude that lipocortin I is present in relatively large amounts in human alveolar macrophages and that amounts of the protein can be induced by corticosteroids. We further speculate that the relative amounts of lipocortin I within monocytes/macrophages may be a marker of differentiation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1530812     DOI: 10.1165/ajrcmb/6.1.17

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  9 in total

1.  Mainstream and sidestream cigarette smoke exposure increases Ca2+-dependent phospholipid binding proteins in guinea pig alveolar type II cells.

Authors:  Salil K Das; Francis H C Tsao; Shyamali Mukherjee
Journal:  Mol Cell Biochem       Date:  2002-02       Impact factor: 3.396

2.  Stimulus-specific defect in the phagocytic pathways of annexin 1 null macrophages.

Authors:  Simon Yona; Julia C Buckingham; Mauro Perretti; Roderick J Flower
Journal:  Br J Pharmacol       Date:  2004-06-14       Impact factor: 8.739

3.  Glucocorticoid deficiency increases phospholipase A2 activity in rats.

Authors:  B S Vishwanath; F J Frey; M J Bradbury; M F Dallman; B M Frey
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

4.  Glucocorticoid-induced annexin 1 secretion by monocytes and peritoneal leukocytes.

Authors:  C Coméra; F Russo-Marie
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

5.  Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis.

Authors:  Amílcar S Damazo; André Lf Sampaio; Cintia Mag Nakata; Roderick J Flower; Mauro Perretti; Sonia M Oliani
Journal:  BMC Immunol       Date:  2011-10-19       Impact factor: 3.615

6.  Annexin 1 localisation in tissue eosinophils as detected by electron microscopy.

Authors:  Sonia M Oliani; Amilcar S Damazo; Mauro Perretti
Journal:  Mediators Inflamm       Date:  2002-10       Impact factor: 4.711

7.  Expression of lipocortins in human bronchial epithelial cells: effects of IL-1beta , TNF-alpha, LPS and dexamethasone.

Authors:  M M Verheggen; H I Bont; P W Adriaansen-Soeting; B J Goense; C J Tak; H C Hoogsteden; P T Hal; M A Versnel
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

Review 8.  The Potential Therapeutic Application of Peptides and Peptidomimetics in Cardiovascular Disease.

Authors:  Carlota Recio; Francesco Maione; Asif J Iqbal; Nicola Mascolo; Vincenzo De Feo
Journal:  Front Pharmacol       Date:  2017-01-06       Impact factor: 5.810

9.  Reduction of nitric oxide release from alveolar macrophages by a lipocortin peptide.

Authors:  A M Kamal; T D Tetley; I R Witherden; S F Smith
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.